A randomized, open label, interventional clinical study to assess the Efficacyand Safety of EMCOF cough syrup for the symptomatic treatment of acuteand Chronic Productive and non-productive cough . - NI

Medopharm0 个研究点目标入组 50 人开始时间: 待定最近更新: 2023年12月19日

试验速览

暂无简介。

•1. Patients willing to provide written informed consent to participate in the study
•2. Male and Female patient in the age range of 10-65 years.
•3. Patients with acute and Chronic,Productive or non-productive cough (Dry cough, Wet cough, Asthmatic cough, Allergic cough, Infective cough, Smokers cough, Sore throat, Hoarse cough, Ratting / Tickling cough) presenting in out patient setting.
•4. Patients with a baseline daytime cough symptom score of at least 2.

•1. Female patient who is pregnant or lactating.
•2. Patients or with clinically suspected lower respiratory tract infection (e.g. pneumonia tuberculosis)
•3. Patients taking any other antitussives, sleeping pills, sedative medications, or herbal cough remedies;
•4. Patients currently on any treatments that may influence cough.
•5. Patient has history of hepatic or renal insufficiency
•6. History of hypersensitivity to any of the test products.
•7. Any condition decided as unfit for study by Clinical investigator

发起方

Medopharm